QA: Alimera Sciences INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2018_Alimera_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}

Graph

Absolute values for 0001267602, Alimera Sciences INC

  xvar xval
0 AssetsCurrent 39,322,000
1 IntangibleAssetsNetIncludingGoodwill 18,664,000
2 PropertyPlantAndEquipmentNet 1,410,000
3 remainder_Assets 528,000
4 LiabilitiesCurrent 9,671,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,202,110
9 ResearchAndDevelopmentExpense 12,899,488
10 remainder_Expenses 31,572,576
11 remainder_Revenues 39,565,467
12 remainder_NetIncome 149,912
13 remainder_ComprehensiveNetIncome 529,743
  yvar yval
0 Assets 59,924,000
1 Liabilities 9,671,000
2 Expenses 56,674,174
3 Revenues 39,565,467
4 StockholdersEquity 50,253,000
5 NetIncome -16,958,795
6 ComprehensiveNetIncome -16,693,924
7 BaseVar 83,257,148
8 EconomicCapitalRatiobeforeLimitedLiability 2.67
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution

Change over Time